• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧氟沙星在支气管分泌物中的渗透情况。 (注:原文中多了一个of,正确表述应该是Penetration of ofloxacin into bronchial secretions. )

Penetration of ofloxacin into bronchial secretions.

作者信息

Symonds J, Bone M, Turner A, Javaid A

机构信息

Department of Microbiology, Russels Hall Hospital, Dudley.

出版信息

Drugs. 1987;34 Suppl 1:33-6. doi: 10.2165/00003495-198700341-00008.

DOI:10.2165/00003495-198700341-00008
PMID:3481325
Abstract

The penetration of ofloxacin into bronchial secretions was evaluated in 16 patients after administration of a single oral dose of ofloxacin 400mg. Bronchial secretions were aspirated at bronchoscopy after 1 to 6 hours and serum was collected simultaneously. Ofloxacin concentrations were measured by a microbiological assay method. Considerable individual variations in serum and bronchial aspirate concentrations were recorded: bronchial aspirate concentrations varied between 1.1 mg/L and 4.5 mg/L but exceeded 1.5 mg/L in 14 of 16 patients between 1 and 6 hours. The ratio between simultaneous mean bronchial aspirate and serum concentrations ranged between 0.53 in the second hour and 0.92 in the fourth hour. It is likely that inhibitory activity will be sustained over at least 6 hours against most potential respiratory pathogens including Haemophilus influenzae, Branhamella catarrhalis, Gram-negative bacilli, Staphylococcus aureus, Legionella pneumophila and Mycoplasma pneumoniae. Streptococcus pneumoniae and Pseudomonas aeruginosa may have minimal inhibitory concentration (MIC) values lower than ofloxacin concentrations achieved in bronchial secretions, although some isolates are less sensitive. Clinical studies should establish the relevance of pharmacokinetic data to respiratory infections caused by organisms of borderline susceptibility.

摘要

在16例患者单次口服400mg氧氟沙星后,评估了氧氟沙星在支气管分泌物中的渗透情况。在1至6小时后通过支气管镜检查抽吸支气管分泌物,并同时采集血清。采用微生物测定法测量氧氟沙星浓度。记录到血清和支气管抽吸物浓度存在相当大的个体差异:支气管抽吸物浓度在1.1mg/L至4.5mg/L之间变化,但在16例患者中有14例在1至6小时内超过1.5mg/L。同时期支气管抽吸物平均浓度与血清浓度之比在第二小时为0.53,在第四小时为0.92。对于包括流感嗜血杆菌、卡他莫拉菌、革兰氏阴性杆菌、金黄色葡萄球菌、嗜肺军团菌和肺炎支原体在内的大多数潜在呼吸道病原体,抑制活性可能至少持续6小时。肺炎链球菌和铜绿假单胞菌的最低抑菌浓度(MIC)值可能低于支气管分泌物中达到的氧氟沙星浓度,尽管一些分离株敏感性较低。临床研究应确定药代动力学数据与由临界敏感性微生物引起的呼吸道感染之间的相关性。

相似文献

1
Penetration of ofloxacin into bronchial secretions.氧氟沙星在支气管分泌物中的渗透情况。 (注:原文中多了一个of,正确表述应该是Penetration of ofloxacin into bronchial secretions. )
Drugs. 1987;34 Suppl 1:33-6. doi: 10.2165/00003495-198700341-00008.
2
Ofloxacin concentrations in tissues involved in respiratory tract infections.呼吸道感染相关组织中的氧氟沙星浓度。
J Antimicrob Chemother. 1990 Nov;26 Suppl D:55-60. doi: 10.1093/jac/26.suppl_d.55.
3
The penetration of ofloxacin into bronchial secretions.氧氟沙星在支气管分泌物中的渗透情况。 (注:原英文中多了一个of,正确表述应该是The penetration of ofloxacin into bronchial secretions. )
J Antimicrob Chemother. 1988 Sep;22 Suppl C:91-5. doi: 10.1093/jac/22.supplement_c.91.
4
Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.单次及多次口服给药后洛美沙星在支气管分泌物中的渗透情况。
Am J Med. 1992 Apr 6;92(4A):8S-11S. doi: 10.1016/0002-9343(92)90299-q.
5
[Diffusion of an orally administered single dose of ofloxacin into human bronchial mucus].
Pathol Biol (Paris). 1986 May;34(5):353-6.
6
Evaluation of the effects of ambroxol on the ofloxacin concentrations in bronchial tissues in COPD patients with infectious exacerbation.氨溴索对慢性阻塞性肺疾病(COPD)感染加重期患者支气管组织中氧氟沙星浓度影响的评估。
Biopharm Drug Dispos. 1995 Jul;16(5):393-401. doi: 10.1002/bdd.2510160504.
7
Tissue concentrations of ofloxacin in the middle ear.中耳中氧氟沙星的组织浓度。 (注:原文中多了一个of,正确表述应该是Tissue concentrations of ofloxacin in the middle ear.)
Clin Ther. 1987;9(5):523-7.
8
Penetration of ofloxacin from blood to sputum.
Drugs. 1987;34 Suppl 1:26-32. doi: 10.2165/00003495-198700341-00007.
9
Penetration of danofloxacin into the respiratory tract tissues and secretions in calves.
Am J Vet Res. 1993 Jul;54(7):1122-7.
10
Bronchoscopic microsampling method for measuring drug concentration in epithelial lining fluid.用于测量上皮衬液中药物浓度的支气管镜微量采样方法。
Am J Respir Crit Care Med. 2003 Dec 1;168(11):1304-7. doi: 10.1164/rccm.200301-111OC. Epub 2003 Aug 6.

引用本文的文献

1
Haemophilus influenzae type b conjugate vaccines.b型流感嗜血杆菌结合疫苗
Immunology. 2004 Oct;113(2):163-74. doi: 10.1111/j.1365-2567.2004.01971.x.
2
Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.氟喹诺酮类抗生素。微生物学、药代动力学及临床应用。
Drugs. 1988 Aug;36(2):193-228. doi: 10.2165/00003495-198836020-00004.
3
Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue.血清、胆汁及胆囊壁组织中氧氟沙星的术中浓度。

本文引用的文献

1
The pharmacokinetics and tissue penetration of ofloxacin.氧氟沙星的药代动力学和组织穿透性。 (注:原文中多了一个of,正确表述应该是The pharmacokinetics and tissue penetration of ofloxacin )
J Antimicrob Chemother. 1984 Dec;14(6):647-52. doi: 10.1093/jac/14.6.647.
2
Antimycoplasmal activity of ofloxacin (DL-8280).氧氟沙星(DL-8280)的抗支原体活性。
Antimicrob Agents Chemother. 1983 Mar;23(3):509-11. doi: 10.1128/AAC.23.3.509.
3
Susceptibility of Legionella spp. to quinolone derivatives and related organic acids.军团菌属对喹诺酮衍生物及相关有机酸的敏感性。
Antimicrob Agents Chemother. 1990 Dec;34(12):2354-7. doi: 10.1128/AAC.34.12.2354.
4
Ofloxacin clinical pharmacokinetics.氧氟沙星的临床药代动力学。
Clin Pharmacokinet. 1992 Jan;22(1):32-46. doi: 10.2165/00003088-199222010-00004.
Eur J Clin Microbiol. 1984 Aug;3(4):373. doi: 10.1007/BF01977502.
4
In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents.喹诺酮羧酸类药物氧氟沙星与其他喹诺酮类药物及其他抗菌药物的体外活性比较。
J Antimicrob Chemother. 1985 Nov;16(5):563-74. doi: 10.1093/jac/16.5.563.
5
Pefloxacin in acute exacerbations of chronic bronchitis.培氟沙星用于慢性支气管炎急性加重期。
J Antimicrob Chemother. 1985 Sep;16(3):379-88. doi: 10.1093/jac/16.3.379.
6
Quinolones in chest infections.
J Antimicrob Chemother. 1986 Sep;18(3):296-9. doi: 10.1093/jac/18.3.296.
7
Ofloxacin: serum and skin blister fluid pharmacokinetics in the fasting and non-fasting state.氧氟沙星:禁食和非禁食状态下的血清及皮肤水疱液药代动力学
J Antimicrob Chemother. 1986 Jun;17(6):795-800. doi: 10.1093/jac/17.6.795.
8
The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin.依诺沙星和氧氟沙星的体外活性与环丙沙星的比较。
J Antimicrob Chemother. 1985 May;15(5):551-8. doi: 10.1093/jac/15.5.551.
9
Comparative in vitro activity of the new quinolone CI-934.新型喹诺酮CI-934的体外活性比较
Eur J Clin Microbiol. 1986 Jun;5(3):343-5. doi: 10.1007/BF02017794.
10
Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis.环丙沙星治疗慢性支气管炎急性加重期
Eur J Clin Microbiol. 1986 Apr;5(2):226-31. doi: 10.1007/BF02013995.